BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shrotriya S, Walsh D, Bennani-Baiti N, Thomas S, Lorton C. C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review. PLoS One 2015;10:e0143080. [PMID: 26717416 DOI: 10.1371/journal.pone.0143080] [Cited by in Crossref: 113] [Cited by in F6Publishing: 116] [Article Influence: 16.1] [Reference Citation Analysis]
Number Citing Articles
1 Kong F, Gao F, Chen J, Zheng R, Liu H, Li X, Yang P, Liu G, Jia Y. Elevated serum C-reactive protein level predicts a poor prognosis for recurrent gastric cancer. Oncotarget 2016;7:55765-70. [PMID: 27303917 DOI: 10.18632/oncotarget.9910] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
2 Kao HK, Löfstrand J, Loh CY, Lao WW, Yi JS, Chang YL, Chang KP. Nomogram based on albumin and neutrophil-to-lymphocyte ratio for predicting the prognosis of patients with oral cavity squamous cell carcinoma. Sci Rep 2018;8:13081. [PMID: 30166572 DOI: 10.1038/s41598-018-31498-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
3 Fukuda T, Kawanishi M, Awazu Y, Nanno S, Shimomura M, Inoue Y, Matsubara H, Yamauchi M, Kasai M, Hashiguchi Y, Ichimura T, Yasui T, Sumi T. Neutrophil-to-lymphocyte ratio is associated with sensitivity to platinum-based chemotherapy and prognosis in patients with advanced serous ovarian carcinoma. Mol Clin Oncol 2021;15:217. [PMID: 34476101 DOI: 10.3892/mco.2021.2381] [Reference Citation Analysis]
4 Jomrich G, Paireder M, Gleiss A, Kristo I, Harpain L, Schoppmann SF. Comparison of Inflammation-Based Prognostic Scores in a Cohort of Patients with Resectable Esophageal Cancer. Gastroenterol Res Pract 2017;2017:1678584. [PMID: 28740506 DOI: 10.1155/2017/1678584] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
5 Kaur M. C-reactive Protein: A Prognostic Indicator. Int J Appl Basic Med Res 2017;7:83-4. [PMID: 28584735 DOI: 10.4103/ijabmr.IJABMR_63_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
6 Janik S, Bekos C, Hacker P, Raunegger T, Ghanim B, Einwallner E, Beer L, Klepetko W, Müllauer L, Ankersmit HJ, Moser B. Elevated CRP levels predict poor outcome and tumor recurrence in patients with thymic epithelial tumors: A pro- and retrospective analysis. Oncotarget 2017;8:47090-102. [PMID: 28514756 DOI: 10.18632/oncotarget.17478] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
7 Nieder C, Tollåli T, Haukland E, Reigstad A, Randi Flatøy L, Dalhaug A. A Four-Tiered Prognostic Score for Patients Receiving Palliative Thoracic Radiotherapy for Lung Cancer. Cancer Investigation 2018;36:59-65. [DOI: 10.1080/07357907.2017.1416394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
8 Aarstad HH, Guðbrandsdottir G, Hjelle KM, Bostad L, Bruserud Ø, Tvedt THA, Beisland C. The Biological Context of C-Reactive Protein as a Prognostic Marker in Renal Cell Carcinoma: Studies on the Acute Phase Cytokine Profile. Cancers (Basel) 2020;12:E1961. [PMID: 32707675 DOI: 10.3390/cancers12071961] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
9 Kristeleit R, Davidenko I, Shirinkin V, El-khouly F, Bondarenko I, Goodheart MJ, Gorbunova V, Penning CA, Shi JG, Liu X, Newton RC, Zhao Y, Maleski J, Leopold L, Schilder RJ. A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)–only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer. Gynecologic Oncology 2017;146:484-90. [DOI: 10.1016/j.ygyno.2017.07.005] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 9.2] [Reference Citation Analysis]
10 Køstner AH, Kersten C, Löwenmark T, Ydsten KA, Peltonen R, Isoniemi H, Haglund C, Gunnarsson U, Isaksson B. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker. J Surg Oncol 2016;114:895-9. [PMID: 27696432 DOI: 10.1002/jso.24415] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
11 Gao N, Yang RN, Meng Z, Wang WH. The prognostic value of C-reactive protein/albumin ratio in nasopharyngeal carcinoma: a meta-analysis. Biosci Rep 2018;38:BSR20180686. [PMID: 30352836 DOI: 10.1042/BSR20180686] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
12 Pan L, Zhou Y, Yin H, Hui H, Guo Y, Xie X. Omega-3 Polyunsaturated Fatty Acids Can Reduce C-Reactive Protein in Patients with Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutr Cancer 2021;:1-12. [PMID: 34060403 DOI: 10.1080/01635581.2021.1931365] [Reference Citation Analysis]
13 Gibney GT, Hamid O, Lutzky J, Olszanski AJ, Mitchell TC, Gajewski TF, Chmielowski B, Hanks BA, Zhao Y, Newton RC, Maleski J, Leopold L, Weber JS. Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma. J Immunother Cancer 2019;7:80. [PMID: 30894212 DOI: 10.1186/s40425-019-0562-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 10.7] [Reference Citation Analysis]
14 Buder-Bakhaya K, Hassel JC. Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-A Review From the Melanoma Perspective and Beyond. Front Immunol 2018;9:1474. [PMID: 30002656 DOI: 10.3389/fimmu.2018.01474] [Cited by in Crossref: 104] [Cited by in F6Publishing: 101] [Article Influence: 26.0] [Reference Citation Analysis]
15 Leuzzi G, Galeone C, Gisabella M, Duranti L, Taverna F, Suatoni P, Morelli D, Pastorino U. Baseline C-reactive protein level predicts survival of early-stage lung cancer: evidence from a systematic review and meta-analysis. Tumori 2016;102:441-9. [PMID: 27292573 DOI: 10.5301/tj.5000522] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
16 Shrotriya S, Walsh D, Nowacki AS, Lorton C, Aktas A, Hullihen B, Benanni-Baiti N, Hauser K, Ayvaz S, Estfan B. Serum C-reactive protein is an important and powerful prognostic biomarker in most adult solid tumors. PLoS One 2018;13:e0202555. [PMID: 30138391 DOI: 10.1371/journal.pone.0202555] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
17 Hang J, Xue P, Yang H, Li S, Chen D, Zhu L, Huang W, Ren S, Zhu Y, Wang L. Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients. Sci Rep 2017;7:2993. [PMID: 28592881 DOI: 10.1038/s41598-017-03153-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
18 Zheng C, Wang J, Xie S. Ultrasound-Guided Thoracic Paravertebral Nerve Block on Postoperative Pain, Quality of Life, and Recovery in Patients with Non-Small-Cell Lung Cancer. Biomed Res Int 2021;2021:6692815. [PMID: 33628809 DOI: 10.1155/2021/6692815] [Reference Citation Analysis]
19 Abolhassani AR, Schuler G, Kirchberger MC, Heinzerling L. C-reactive protein as an early marker of immune-related adverse events. J Cancer Res Clin Oncol 2019;145:2625-31. [PMID: 31492984 DOI: 10.1007/s00432-019-03002-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
20 Ding Y, Zhang S, Qiao J. Prognostic value of neutrophil-to-lymphocyte ratio in melanoma: Evidence from a PRISMA-compliant meta-analysis. Medicine (Baltimore) 2018;97:e11446. [PMID: 30045267 DOI: 10.1097/MD.0000000000011446] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
21 Kim DS, Yu ES, Kang KW, Lee SR, Park Y, Sung HJ, Choi CW, Kim BS. Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma. Korean J Intern Med 2017;32:711-21. [PMID: 27809455 DOI: 10.3904/kjim.2016.054] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
22 Garzia NA, Cushing-Haugen K, Kensler TW, Tamimi RM, Harris HR. Adolescent and early adulthood inflammation-associated dietary patterns in relation to premenopausal mammographic density. Breast Cancer Res 2021;23:71. [PMID: 34233736 DOI: 10.1186/s13058-021-01449-0] [Reference Citation Analysis]
23 Cui X, Jia Z, Chen D, Xu C, Yang P. The prognostic value of the C-reactive protein to albumin ratio in cancer: An updated meta-analysis. Medicine (Baltimore) 2020;99:e19165. [PMID: 32243358 DOI: 10.1097/MD.0000000000019165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
24 Hwang KT, Chung JK, Roh EY, Kim J, Oh S, Kim YA, Rhu J, Kim S. Prognostic Influence of Preoperative Fibrinogen to Albumin Ratio for Breast Cancer. J Breast Cancer. 2017;20:254-263. [PMID: 28970851 DOI: 10.4048/jbc.2017.20.3.254] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
25 Jensen GL, Naziri J, Hammonds KP, Jhavar SG, Swanson G. C-Reactive Protein Is a Poor Marker of Baseline Inflammation in Prostate Cancer and Response to Radiotherapy or Androgen Ablation. Cureus 2021;13:e19639. [PMID: 34926085 DOI: 10.7759/cureus.19639] [Reference Citation Analysis]
26 Wu J, Tan W, Chen L, Huang Z, Mai S. Clinicopathologic and prognostic significance of C-reactive protein/albumin ratio in patients with solid tumors: an updated systemic review and meta-analysis. Oncotarget 2018;9:13934-47. [PMID: 29568406 DOI: 10.18632/oncotarget.24172] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
27 Gan W, Yi Y, Fu Y, Huang J, Lu Z, Jing C, Fan J, Zhou J, Qiu S. Fibrinogen and C-reactive protein score is a prognostic index for patients with hepatocellular carcinoma undergoing curative resection: a prognostic nomogram study. J Cancer 2018;9:148-56. [PMID: 29290780 DOI: 10.7150/jca.22246] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
28 Versluis JM, Long GV, Blank CU. Learning from clinical trials of neoadjuvant checkpoint blockade. Nat Med 2020;26:475-84. [PMID: 32273608 DOI: 10.1038/s41591-020-0829-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
29 Pennel KAF, Park JH, McMillan DC, Roseweir AK, Edwards J. Signal interaction between the tumour and inflammatory cells in patients with gastrointestinal cancer: Implications for treatment. Cell Signal. 2019;54:81-90. [PMID: 30453014 DOI: 10.1016/j.cellsig.2018.11.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
30 Ni XC, Xu J, Yi Y, Fu YP, Cai XY, Liu G, Huang JL, Gan W, Qiu SJ. Inflammation-nutrition score predicts prognosis of patients with resectable hepatocellular carcinoma. Int J Clin Oncol 2019;24:825-35. [PMID: 31020447 DOI: 10.1007/s10147-019-01402-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
31 Chinnadayyala SR, Park J, Kim YH, Choi SH, Lee SM, Cho WW, Lee GY, Pyun JC, Cho S. Electrochemical Detection of C-Reactive Protein in Human Serum Based on Self-Assembled Monolayer-Modified Interdigitated Wave-Shaped Electrode. Sensors (Basel) 2019;19:E5560. [PMID: 31888286 DOI: 10.3390/s19245560] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
32 Barhli A, Cros J, Bartholin L, Neuzillet C. Prognostic stratification of resected pancreatic ductal adenocarcinoma: Past, present, and future. Dig Liver Dis 2018;50:979-90. [PMID: 30205952 DOI: 10.1016/j.dld.2018.08.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
33 Tai SF, Chien HT, Young CK, Tsao CK, de Pablo A, Fan KH, Liao CT, Wang HM, Kang CJ, Chang JT, Huang SF. Roles of preoperative C-reactive protein are more relevant in buccal cancer than other subsites. World J Surg Oncol 2017;15:47. [PMID: 28209200 DOI: 10.1186/s12957-017-1116-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
34 Kouzu K, Tsujimoto H, Kishi Y, Ueno H, Shinomiya N. Role of Microbial Infection-Induced Inflammation in the Development of Gastrointestinal Cancers. Medicines (Basel) 2021;8:45. [PMID: 34436224 DOI: 10.3390/medicines8080045] [Reference Citation Analysis]
35 Zhou Q, Hong L, Zuo MZ, He Z. Prognostic significance of neutrophil to lymphocyte ratio in ovarian cancer: evidence from 4,910 patients. Oncotarget 2017;8:68938-49. [PMID: 28978169 DOI: 10.18632/oncotarget.20196] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
36 Sugiyama Y, Naiki T, Tasaki Y, Kondo Y, Kataoka T, Etani T, Iida K, Nozaki S, Ando R, Osaga S, Yasui T, Kimura K. Prognostic significance of hyponatremia induced by systemic chemotherapy in a hospital-based propensity score-matched analysis. Int J Clin Oncol 2020;25:541-51. [PMID: 31811602 DOI: 10.1007/s10147-019-01579-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Zou J, Li Q, Kou F, Zhu Y, Lu M, Li J, Lu Z, Shen L. Prognostic value of inflammation-based markers in advanced or metastatic neuroendocrine tumours. Curr Oncol. 2019;26:e30-e38. [PMID: 30853807 DOI: 10.3747/co.26.4135] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
38 Conroy G, Salleron J, Belle A, Bensenane M, Nani A, Ayav A, Peiffert D, Lopez A, Baumann C, Barraud H, Bronowicki JP. The prognostic value of inflammation-based scores in advanced hepatocellular carcinoma patients prior to treatment with sorafenib. Oncotarget 2017;8:95853-64. [PMID: 29221172 DOI: 10.18632/oncotarget.21401] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
39 Ludwig JM, Haubold J, Bauer S, Richly H, Siveke JT, Wimmer J, Umutlu L, Schaarschmidt BM, Theysohn JM. Predictive impact of the inflammation-based indices in uveal melanoma liver metastases treated with transarterial hepatic chemoperfusion. Radiol Oncol 2021;55:347-53. [PMID: 34051707 DOI: 10.2478/raon-2021-0027] [Reference Citation Analysis]
40 Li Y, Zhang C, Ji R, Lu H, Zhang W, Li L, Liu R, Qian H, He A. Prognostic significance of the controlling nutritional status (CONUT) score in epithelial ovarian cancer. Int J Gynecol Cancer 2020;30:74-82. [DOI: 10.1136/ijgc-2019-000865] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
41 Leuzzi G, Galeone C, Taverna F, Suatoni P, Morelli D, Pastorino U. C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis. Eur Respir Rev 2017;26:160070. [PMID: 28143876 DOI: 10.1183/16000617.0070-2016] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
42 Goryca K, Kulecka M, Paziewska A, Dabrowska M, Grzelak M, Skrzypczak M, Ginalski K, Mroz A, Rutkowski A, Paczkowska K, Mikula M, Ostrowski J. Exome scale map of genetic alterations promoting metastasis in colorectal cancer. BMC Genet 2018;19:85. [PMID: 30231850 DOI: 10.1186/s12863-018-0673-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
43 Dalpiaz O, Luef T, Seles M, Stotz M, Stojakovic T, Pummer K, Zigeuner R, Hutterer GC, Pichler M. Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma. Br J Cancer 2017;116:85-90. [PMID: 27907929 DOI: 10.1038/bjc.2016.393] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
44 Tam V, Luketich JD, Winger DG, Sarkaria IS, Levy RM, Christie NA, Awais O, Shende MR, Nason KS. Cancer Recurrence After Esophagectomy: Impact of Postoperative Infection in Propensity-Matched Cohorts. Ann Thorac Surg 2016;102:1638-46. [PMID: 27353482 DOI: 10.1016/j.athoracsur.2016.04.097] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
45 Conrad DM, Hoskin DW, Liwski R, Naugler C. A re-examination of the role of the acute phase protein response in innate cancer defence. Med Hypotheses 2016;93:93-6. [PMID: 27372864 DOI: 10.1016/j.mehy.2016.05.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
46 Struck JP, Hupe MC, Heinisch A, Ozimek T, Hennig MJP, Klee M, von Klot C, Kalogirou C, Kuczyk MA, Merseburger AS, Kramer MW. RLC score (R status, lymphovascular invasion, C-reactive protein) predicts survival following radical cystectomy for muscle-invasive bladder cancer. Aktuelle Urol 2021. [PMID: 33445183 DOI: 10.1055/a-1310-3583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Berg J, Halvorsen AR, Bengtson MB, Taskén KA, Mælandsmo GM, Yndestad A, Halvorsen B, Brustugun OT, Aukrust P, Ueland T, Helland Å. Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease. BMC Cancer 2018;18:739. [PMID: 30005623 DOI: 10.1186/s12885-018-4659-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
48 Wach J, Güresir Á, Borger V, Schuss P, Becker A, Coch C, Schmitz MT, Hölzel M, Toma M, Herrlinger U, Vatter H, Güresir E. Elevated baseline C-reactive protein levels predict poor progression-free survival in sporadic vestibular schwannoma. J Neurooncol 2021. [PMID: 34882287 DOI: 10.1007/s11060-021-03918-0] [Reference Citation Analysis]
49 Rajab IM, Hart PC, Potempa LA. How C-Reactive Protein Structural Isoforms With Distinctive Bioactivities Affect Disease Progression. Front Immunol 2020;11:2126. [PMID: 33013897 DOI: 10.3389/fimmu.2020.02126] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
50 Wang R, Shao X, Zheng J, Saci A, Qian X, Pak I, Roy A, Bello A, Rizzo JI, Hosein F, Moss RA, Wind-Rotolo M, Feng Y. A Machine-Learning Approach to Identify a Prognostic Cytokine Signature That Is Associated With Nivolumab Clearance in Patients With Advanced Melanoma. Clin Pharmacol Ther 2020;107:978-87. [PMID: 31721173 DOI: 10.1002/cpt.1724] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
51 Dillekås H, Straume O. The link between wound healing and escape from tumor dormancy. Surg Oncol 2019;28:50-6. [PMID: 30851911 DOI: 10.1016/j.suronc.2018.11.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
52 Bernhardt D, Aufderstrasse S, König L, Adeberg S, Bozorgmehr F, Christopoulos P, Shafie RAE, Hörner-Rieber J, Kappes J, Thomas M, Herth F, Steins M, Debus J, Rieken S. Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy. Cancer Manag Res 2018;10:6563-9. [PMID: 30555261 DOI: 10.2147/CMAR.S180990] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
53 Watson J, Whiting P, Salisbury C, Banks J, Hamilton W. Raised inflammatory markers as a predictor of one-year mortality: a cohort study in primary care in the UK using electronic health record data. BMJ Open 2020;10:e036027. [PMID: 33060080 DOI: 10.1136/bmjopen-2019-036027] [Reference Citation Analysis]
54 Hart PC, Rajab IM, Alebraheem M, Potempa LA. C-Reactive Protein and Cancer-Diagnostic and Therapeutic Insights. Front Immunol 2020;11:595835. [PMID: 33324413 DOI: 10.3389/fimmu.2020.595835] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
55 De Meue E, Smeijers S, Langmans C, Clement PM, Depreitere B. Identifying new predictive factors for survival after surgery for spinal metastases: an exploratory in-depth retrospective analysis. Acta Clin Belg 2021;:1-10. [PMID: 33956576 DOI: 10.1080/17843286.2021.1925028] [Reference Citation Analysis]
56 Pastorino U, Morelli D, Leuzzi G, Gisabella M, Suatoni P, Taverna F, Bertocchi E, Boeri M, Sozzi G, Cantarutti A, Corrao G. Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancer. Eur J Cancer 2017;79:90-7. [PMID: 28472743 DOI: 10.1016/j.ejca.2017.03.020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
57 Frühling P, Urdzik J, Strömberg C, Isaksson B. Composite Score: prognostic tool to predict survival in patients undergoing surgery for colorectal liver metastases. BJS Open 2021;5:zrab104. [PMID: 34697642 DOI: 10.1093/bjsopen/zrab104] [Reference Citation Analysis]
58 Brown JC, Zhang S, Ligibel JA, Irwin ML, Jones LW, Campbell N, Pollak MN, Sorrentino A, Cartmel B, Harrigan M, Tolaney SM, Winer EP, Ng K, Abrams TA, Sanft T, Douglas PS, Hu FB, Fuchs CS, Meyerhardt JA. Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: A Randomized Trial. Cancer Prev Res (Phila) 2020;13:1055-62. [PMID: 32859615 DOI: 10.1158/1940-6207.CAPR-20-0188] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
59 Ma Z, Qi Z, Shan Z, Li J, Yang J, Xu Z. The role of CRP and ATG9B expression in clear cell renal cell carcinoma. Biosci Rep 2017;37:BSR20171082. [PMID: 28923830 DOI: 10.1042/BSR20171082] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
60 Ito T, Shinkawa H, Takemura S, Tanaka S, Nishioka T, Miyazaki T, Ishihara A, Kubo S. Impact of the Preoperative C-reactive Protein to Albumin Ratio on the Long-Term Outcomes of Hepatic Resection for Intrahepatic Cholangiocarcinoma. Asian Pac J Cancer Prev 2020;21:2373-9. [PMID: 32856868 DOI: 10.31557/APJCP.2020.21.8.2373] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Kajioka H, Kagawa S, Ito A, Yoshimoto M, Sakamoto S, Kikuchi S, Kuroda S, Yoshida R, Umeda Y, Noma K, Tazawa H, Fujiwara T. Targeting neutrophil extracellular traps with thrombomodulin prevents pancreatic cancer metastasis.Cancer Lett. 2021;497:1-13. [PMID: 33065249 DOI: 10.1016/j.canlet.2020.10.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
62 Riedl JM, Posch F, Moik F, Bezan A, Szkandera J, Smolle MA, Kasparek AK, Pichler M, Stöger H, Stotz M, Gerger A. Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting. Oncotarget 2017;8:96048-61. [PMID: 29221186 DOI: 10.18632/oncotarget.21647] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
63 Lu J, Xu BB, Xue Z, Xie JW, Zheng CH, Huang CM, Li P. Perioperative CRP: A novel inflammation-based classification in gastric cancer for recurrence and chemotherapy benefit. Cancer Med 2021;10:34-44. [PMID: 33270989 DOI: 10.1002/cam4.3514] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Frühling P, Hellberg K, Ejder P, Strömberg C, Urdzik J, Isaksson B. The prognostic value of C-reactive protein and albumin in patients undergoing resection of colorectal liver metastases. A retrospective cohort study. HPB (Oxford) 2021;23:970-8. [PMID: 33214053 DOI: 10.1016/j.hpb.2020.10.019] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Matsuo Y, Nagata Y, Wakabayashi M, Ishikura S, Onishi H, Kokubo M, Karasawa K, Shioyama Y, Onimaru R, Hiraoka M. Impact of pre-treatment C-reactive protein level and skeletal muscle mass on outcomes after stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer: a supplementary analysis of the Japan Clinical Oncology Group study JCOG0403. J Radiat Res 2021:rrab065. [PMID: 34350956 DOI: 10.1093/jrr/rrab065] [Reference Citation Analysis]
66 Watabe Y, Aoki K, Ichikawa H, Matsuzaki H, Ito A, Tanaka JI, Kamiyama I, Shigematsu S. A preoperative prognostic nutritional index is a prognostic indicator in oral squamous cell carcinoma patients undergoing radical surgery. Int J Oral Maxillofac Surg 2021:S0901-5027(21)00028-X. [PMID: 33663900 DOI: 10.1016/j.ijom.2021.01.009] [Reference Citation Analysis]
67 Njoku K, Ramchander NC, Wan YL, Barr CE, Crosbie EJ. Pre-treatment inflammatory parameters predict survival from endometrial cancer: A prospective database analysis. Gynecol Oncol 2022;164:146-53. [PMID: 34802721 DOI: 10.1016/j.ygyno.2021.11.009] [Reference Citation Analysis]
68 Shindo Y, Hazama S, Tsunedomi R, Suzuki N, Nagano H. Novel Biomarkers for Personalized Cancer Immunotherapy. Cancers (Basel) 2019;11:E1223. [PMID: 31443339 DOI: 10.3390/cancers11091223] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
69 Du J, Hu W, Yang C, Wang Y, Wang X, Yang P. C-reactive protein is associated with the development of tongue squamous cell carcinoma. Acta Biochimica et Biophysica Sinica 2018;50:238-45. [DOI: 10.1093/abbs/gmy004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
70 Jairath NK, Farha MW, Jairath R, Harms PW, Tsoi LC, Tejasvi T. Prognostic value of intratumoral lymphocyte-to-monocyte ratio and M0 macrophage enrichment in tumor immune microenvironment of melanoma. Melanoma Manag 2020;7:MMT51. [PMID: 33318782 DOI: 10.2217/mmt-2020-0019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Sylman JL, Mitrugno A, Atallah M, Tormoen GW, Shatzel JJ, Tassi Yunga S, Wagner TH, Leppert JT, Mallick P, McCarty OJT. The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis. Front Oncol 2018;8:78. [PMID: 29619344 DOI: 10.3389/fonc.2018.00078] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
72 Guo Y, Cai K, Mao S, Zhang J, Wang L, Zhang Z, Liu M, Zhang W, Wu Y, Yan Y, Yao X. Preoperative C-reactive protein/albumin ratio is a significant predictor of survival in bladder cancer patients after radical cystectomy: a retrospective study. Cancer Manag Res 2018;10:4789-804. [PMID: 30425573 DOI: 10.2147/CMAR.S180301] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
73 Schneider M, Schäfer N, Bode C, Borger V, Eichhorn L, Giordano FA, Güresir E, Heimann M, Ko YD, Lehmann F, Potthoff AL, Radbruch A, Schaub C, Schwab KS, Weller J, Vatter H, Herrlinger U, Landsberg J, Schuss P. Prognostic Value of Preoperative Inflammatory Markers in Melanoma Patients with Brain Metastases. J Clin Med 2021;10:634. [PMID: 33562331 DOI: 10.3390/jcm10040634] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
74 Bruserud Ø, Aarstad HH, Tvedt THA. Combined C-Reactive Protein and Novel Inflammatory Parameters as a Predictor in Cancer-What Can We Learn from the Hematological Experience? Cancers (Basel) 2020;12:E1966. [PMID: 32707721 DOI: 10.3390/cancers12071966] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
75 Pastorino U, Morelli D, Leuzzi G, Rolli L, Suatoni P, Taverna F, Bertocchi E, Boeri M, Sozzi G, Cantarutti A, Corrao G, Gronchi A. Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung Metastasectomy. Ann Surg Oncol 2019;26:869-75. [DOI: 10.1245/s10434-018-07116-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
76 Grossi F, Genova C, Rijavec E, Barletta G, Biello F, Dal Bello MG, Meyer K, Roder J, Roder H, Grigorieva J. Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapy. Lung Cancer 2018;117:64-9. [DOI: 10.1016/j.lungcan.2017.12.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
77 Huertas CS, Soler M, Estevez MC, Lechuga LM. One-Step Immobilization of Antibodies and DNA on Gold Sensor Surfaces via a Poly-Adenine Oligonucleotide Approach. Anal Chem 2020;92:12596-604. [PMID: 32786435 DOI: 10.1021/acs.analchem.0c02619] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
78 Pastorino U, Morelli D, Marchianò A, Sestini S, Suatoni P, Taverna F, Boeri M, Sozzi G, Cantarutti A, Corrao G. Inflammatory status and lung function predict mortality in lung cancer screening participants. Eur J Cancer Prev 2018;27:289-95. [PMID: 28333763 DOI: 10.1097/CEJ.0000000000000342] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
79 Pinto-Paz ME, Cotrina-Concha JM, Benites-Zapata VA. Mortality in cutaneous malignant melanoma and its association with Neutrophil-to-Lymphocyte ratio. Cancer Treat Res Commun 2021;29:100464. [PMID: 34598061 DOI: 10.1016/j.ctarc.2021.100464] [Reference Citation Analysis]
80 Pastorino U, Tagliabue E. Non-Human Determinants of Lung Cancer Outcome: A Target for Inhibition of Pro-Metastatic Effect of Surgery, Triggered by Postoperative Bacterial Pneumonia. J Thorac Oncol 2019;14:2039-41. [PMID: 31757372 DOI: 10.1016/j.jtho.2019.09.084] [Reference Citation Analysis]
81 Wang D, Liu J, Chen Q, Yang R, Jiang Q. Upregulation of glutaminase 2 and neutrophil cytosolic factor 2 is associated with the poor prognosis of glioblastoma. Biomark Med 2020;14:1585-97. [PMID: 33179520 DOI: 10.2217/bmm-2020-0341] [Reference Citation Analysis]
82 Yamagata K, Fukuzawa S, Ishibashi-Kanno N, Uchida F, Bukawa H. Association between the C-reactive protein/albumin ratio and prognosis in patients with oral squamous cell carcinoma. Sci Rep 2021;11:5446. [PMID: 33686103 DOI: 10.1038/s41598-021-83362-2] [Reference Citation Analysis]
83 Son W, Shin SJ, Park SH, Lee SK, Park EJ, Baik SH, Lee KY, Kang J. Clinical Impact of Combined Modified Glasgow Prognostic Score and C-Reactive Protein/Albumin Ratio in Patients with Colorectal Cancer. Diagnostics (Basel) 2020;10:E859. [PMID: 33105743 DOI: 10.3390/diagnostics10110859] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Lorton CM, Higgins L, O'Donoghue N, Donohoe C, O'Connell J, Mockler D, Reynolds JV, Walsh D, Lysaght J. C-Reactive Protein and C-Reactive Protein-Based Scores to Predict Survival in Esophageal and Junctional Adenocarcinoma: Systematic Review and Meta-Analysis. Ann Surg Oncol 2021. [PMID: 34773194 DOI: 10.1245/s10434-021-10988-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Cao X, Zhou Y, Mao F, Lin Y, Sun Q. Combination of preoperative fibrinogen concentration and neutrophil-to-lymphocyte ratio for prediction of the prognosis of patients with resectable breast cancer. Oncol Lett 2020;20:200. [PMID: 32963606 DOI: 10.3892/ol.2020.12061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
86 Johnson-Obaseki S, Caulley L, Corsten M, Liu G, Dimitroulakos J, Goldstein D, Irish J, Rider J. C-reactive Protein in HPV-Positive and HPV-Negative Oropharyngeal Cancer. Otolaryngol Head Neck Surg 2019;160:494-501. [PMID: 30226795 DOI: 10.1177/0194599818800297] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
87 Fujiwara Y, Higashida M, Kubota H, Okamoto Y, Mineta S, Endo S, Ueno T. Perioperative Predictive Markers for Recurrence of Esophageal Cancer after Esophagectomy. Gastrointest Tumors 2021;8:87-95. [PMID: 33981687 DOI: 10.1159/000513961] [Reference Citation Analysis]
88 Chen W, Pilling D, Gomer RH. C-reactive protein (CRP) but not the related pentraxins serum amyloid P and PTX3 inhibits the proliferation and induces apoptosis of the leukemia cell line Mono Mac 6. BMC Immunol 2017;18:47. [PMID: 29202702 DOI: 10.1186/s12865-017-0230-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
89 Kim BR, Chun S, Cho D, Kim KH. Association of neutrophil-to-lymphocyte ratio and natural killer cell activity revealed by measurement of interferon-gamma levels in a healthy population. J Clin Lab Anal 2019;33:e22640. [PMID: 30105845 DOI: 10.1002/jcla.22640] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
90 Xu HJ, Ma Y, Deng F, Ju WB, Sun XY, Wang H. The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis. Onco Targets Ther 2017;10:3059-70. [PMID: 28790840 DOI: 10.2147/OTT.S137002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 6.4] [Reference Citation Analysis]
91 Yuk HD, Ku JH. Role of Systemic Inflammatory Response Markers in Urothelial Carcinoma. Front Oncol 2020;10:1473. [PMID: 32974174 DOI: 10.3389/fonc.2020.01473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
92 Sugawara K, Mori K, Yagi K, Aikou S, Uemura Y, Yamashita H, Seto Y. Association of preoperative inflammation-based prognostic score with survival in patients undergoing salvage esophagectomy. Dis Esophagus 2019;32:doy066. [PMID: 30535140 DOI: 10.1093/dote/doy066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
93 Fang E, Wang X, Feng J, Zhao X. The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis. Dis Markers 2020;2020:8736509. [PMID: 31998420 DOI: 10.1155/2020/8736509] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
94 Cowdery SP, Stuart AL, Pasco JA, Berk M, Campbell D, Bjerkeset O, Williams LJ. Mood disorder and cancer onset: evidence from a population-based sample of Australian women. Braz J Psychiatry 2021;43:355-61. [PMID: 32965431 DOI: 10.1590/1516-4446-2020-0932] [Reference Citation Analysis]
95 Wu G, Liu J, Liu H, Jin L, Huang X, Mo X, Zhong H, Li Y, Zhang Y, Tang W. An Applicable Inflammation-Joined and Nutrition-Related Prognostic Indicator in Patients With Colorectal Cancer. Front Oncol 2021;11:644670. [PMID: 34221966 DOI: 10.3389/fonc.2021.644670] [Reference Citation Analysis]
96 O'Brian D, Prunty M, Hill A, Shoag J. The Role of C-Reactive Protein in Kidney, Bladder, and Prostate Cancers. Front Immunol 2021;12:721989. [PMID: 34512646 DOI: 10.3389/fimmu.2021.721989] [Reference Citation Analysis]
97 Jung J, Lee H, Heo JY, Chang MH, Lee E, Park WS, Park JH, Eom HS. High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma. Sci Rep 2021;11:2674. [PMID: 33514832 DOI: 10.1038/s41598-021-82087-6] [Reference Citation Analysis]
98 Alves A, Dias M, Campainha S, Barroso A. Peripheral blood eosinophilia may be a prognostic biomarker in non-small cell lung cancer patients treated with immunotherapy. J Thorac Dis 2021;13:2716-27. [PMID: 34164164 DOI: 10.21037/jtd-20-3525] [Reference Citation Analysis]
99 Liao TY, Liaw CC. Retrospective Analysis of Mortality Cases in Advanced and Metastatic Solid Tumors With Concurrent Prerenal Azotemia. In Vivo 2020;34:1515-9. [PMID: 32354956 DOI: 10.21873/invivo.11939] [Reference Citation Analysis]
100 Argilés JM, Stemmler B, López-soriano FJ, Busquets S. Inter-tissue communication in cancer cachexia. Nat Rev Endocrinol 2019;15:9-20. [DOI: 10.1038/s41574-018-0123-0] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 19.3] [Reference Citation Analysis]
101 Suner A, Carr BI, Akkiz H, Uskudar O, Kuran S, Tokat Y, Tokmak S, Ballı T, Ulku A, AkCam T, Delik A, Arslan B, Doran F, YalCın K, Ekinci N, Yilmaz S, Ozakyol A, Yücesoy M, BahCeci HI, Polat KY, Şimsek H, Ormeci N, Sonsuz A, Demir M, KılıC M, Uygun A, Demir A, Altıntas E, Karakulah G, Temel T, Bektas A. Inflammatory markers C-reactive protein and PLR in relation to HCC characteristics. J Transl Sci 2019;5. [PMID: 30662766 DOI: 10.15761/JTS.1000260] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
102 Fankhauser CD, Sander S, Roth L, Gross O, Eberli D, Sulser T, Seifert B, Beyer J, Hermanns T. Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy. Br J Cancer 2018;118:825-30. [PMID: 29485982 DOI: 10.1038/bjc.2017.467] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
103 Luo F, Wang Y, Su Y, Zhang Z, Sun H, Li J. Prognostic impact of preoperative anemia on non-muscle-invasive bladder carcinoma treated with GreenLight laser vaporization. Lasers Med Sci 2017;32:397-403. [DOI: 10.1007/s10103-016-2133-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
104 Li B, Wang S, Li C, Guo M, Xu Y, Sun X, Yu J, Wang L. The Kinetic Changes of Systemic Inflammatory Factors during Bevacizumab Treatment and Its Prognostic Role in Advanced Non-small Cell Lung Cancer Patients. J Cancer 2019;10:5082-9. [PMID: 31602260 DOI: 10.7150/jca.30478] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
105 Lybaert L, Vermaelen K, De Geest BG, Nuhn L. Immunoengineering through cancer vaccines – A personalized and multi-step vaccine approach towards precise cancer immunity. Journal of Controlled Release 2018;289:125-45. [DOI: 10.1016/j.jconrel.2018.09.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
106 Shiroyama T, Suzuki H, Tamiya M, Tamiya A, Tanaka A, Okamoto N, Nakahama K, Taniguchi Y, Isa SI, Inoue T, Imamura F, Atagi S, Hirashima T. Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancer. Cancer Med 2018;7:13-20. [PMID: 29150906 DOI: 10.1002/cam4.1234] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 9.6] [Reference Citation Analysis]
107 Michels KB, Keller K, Pereira A, Kim CE, Santos JL, Shepherd J, Corvalan C, Binder AM. Association between indicators of systemic inflammation biomarkers during puberty with breast density and onset of menarche. Breast Cancer Res 2020;22:104. [PMID: 33004039 DOI: 10.1186/s13058-020-01338-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
108 Machado D, Marques C, Dias M, Campainha S, Barroso A. Inflammatory prognostic biomarkers in advanced non-small cell lung cancer. Pulmonology 2019;25:181-3. [PMID: 30935945 DOI: 10.1016/j.pulmoe.2019.02.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
109 Pang Z, Ding N, Dong W, Ni Y, Zhang T, Qu X, Du J, Liu Q. Prognostic effects of preoperative obstructive pneumonitis or atelectasis and comparison with tumor size in non-small cell lung cancer. J Thorac Dis 2017;9:768-78. [PMID: 28449485 DOI: 10.21037/jtd.2017.02.88] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
110 Jia XH, Geng LY, Jiang PP, Xu H, Nan KJ, Yao Y, Jiang LL, Sun H, Qin TJ, Guo H. The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors. J Exp Clin Cancer Res 2020;39:284. [PMID: 33317597 DOI: 10.1186/s13046-020-01749-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
111 McFarland DC, Saracino RM, Miller AH, Breitbart W, Rosenfeld B, Nelson C. Prognostic implications of depression and inflammation in patients with metastatic lung cancer. Future Oncol 2021;17:183-96. [PMID: 33305608 DOI: 10.2217/fon-2020-0632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
112 Ferdosi S, Ho TH, Castle EP, Stanton ML, Borges CR. Behavior of blood plasma glycan features in bladder cancer. PLoS One 2018;13:e0201208. [PMID: 30040854 DOI: 10.1371/journal.pone.0201208] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
113 Martinez-Tapia C, Diot T, Oubaya N, Paillaud E, Poisson J, Gisselbrecht M, Morisset L, Caillet P, Baudin A, Pamoukdjian F, Broussier A, Bastuji-Garin S, Laurent M, Canouï-Poitrine F. The obesity paradox for mid- and long-term mortality in older cancer patients: a prospective multicenter cohort study. Am J Clin Nutr 2020:nqaa238. [PMID: 32889525 DOI: 10.1093/ajcn/nqaa238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
114 Brown JC, Zhang S, Niedzwiecki D, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Ogino S, Li Y, Zhang X, Ng K, Willett WC, Giovannucci EL, Fuchs CS, Meyerhardt JA. Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 (Alliance). JNCI Cancer Spectr 2018;2:pky017. [PMID: 29877501 DOI: 10.1093/jncics/pky017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
115 Zhang F, Qiao S. Research Progress on the Relationship Between Inflammation and Colorectal Cancer. Ann Gastroenterol Surg. [DOI: 10.1002/ags3.12517] [Reference Citation Analysis]
116 Gillis C, Hasil L, Kasvis P, Bibby N, Davies SJ, Prado CM, West MA, Shaw C. Nutrition Care Process Model Approach to Surgical Prehabilitation in Oncology. Front Nutr 2021;8:644706. [PMID: 34249985 DOI: 10.3389/fnut.2021.644706] [Reference Citation Analysis]
117 Park MJ, Roh JL, Kim SB, Choi SH, Nam SY, Kim SY. Prognostic value of circulating biomarker score in advanced-stage head and neck squamous cell carcinoma. Eur J Cancer 2018;92:69-76. [PMID: 29428866 DOI: 10.1016/j.ejca.2018.01.069] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
118 Yan X, Cao M, Wang Z, Wang S, Chen Q. C-reactive protein promotes tongue squamous cell carcinoma chemoresistance by inhibiting the activation of caspase-3/9 via the CD64/AKT/mTOR pathway. Hum Cell 2021;34:1424-33. [PMID: 34019244 DOI: 10.1007/s13577-021-00555-7] [Reference Citation Analysis]
119 Stepanova TV, Ivanov AN, Tereshkina NE, Popyhova EB, Lagutina DD. MARKERS OF ENDOTHELIAL DYSFUNCTION: PATHOGENETIC ROLE AND DIAGNOSTIC SIGNIFICANCE. jour 2019;64:34-41. [DOI: 10.18821/0869-2084-2019-64-1-34-41] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
120 Zhao J, Ji X, Wang Y, Wang X. Clinical Role of Serum Interleukin-17A in the Prediction of Refractory Mycoplasma pneumoniae Pneumonia in Children. Infect Drug Resist 2020;13:835-43. [PMID: 32210598 DOI: 10.2147/IDR.S240034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
121 Atanasov AG, Sabharanjak SM, Zengin G, Mollica A, Szostak A, Simirgiotis M, Huminiecki Ł, Horbanczuk OK, Nabavi SM, Mocan A. Pecan nuts: A review of reported bioactivities and health effects. Trends in Food Science & Technology 2018;71:246-57. [DOI: 10.1016/j.tifs.2017.10.019] [Cited by in Crossref: 53] [Cited by in F6Publishing: 15] [Article Influence: 13.3] [Reference Citation Analysis]
122 Zheng L, Zhao Y, Liu F, Liu P, Li W, Yang Y, Zhang H, Liu Y. Prognostic significance of preoperative albumin to fibrinogen ratio associated nomograms in patients with breast invasive ductal carcinoma. Medicine (Baltimore) 2020;99:e20681. [PMID: 32590741 DOI: 10.1097/MD.0000000000020681] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
123 Naqash AR, Stroud CRG, Butt MU, Dy GK, Hegde A, Muzaffar M, Yang LV, Hafiz M, Cherry CR, Walker PR. Co-relation of overall survival with peripheral blood-based inflammatory biomarkers in advanced stage non-small cell lung cancer treated with anti-programmed cell death-1 therapy: results from a single institutional database. Acta Oncol 2018;57:867-72. [PMID: 29241410 DOI: 10.1080/0284186X.2017.1415460] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
124 Tavares P, Gonçalves DM, Santos LL, Ferreira R. Revisiting the clinical usefulness of C-reactive protein in the set of cancer cachexia. Porto Biomed J 2021;6:e123. [PMID: 33884319 DOI: 10.1097/j.pbj.0000000000000123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Yao WY, Wu XS, Liu SL, Wu ZY, Dong P, Gong W. Preoperative lymphocyte to C-reactive protein ratio as a new prognostic indicator in patients with resectable gallbladder cancer. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00162-4. [PMID: 34507896 DOI: 10.1016/j.hbpd.2021.08.006] [Reference Citation Analysis]